CTO1681
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CTO1681, covering 2026-04-17 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: Study of CTO1681 for the Prevention and Treatment of CRS in DLBCL Patients Receiving CAR T-Cell Therapy [Phase 1, Phase 2]